Last updated on 2022-05-21

Journal of Clinical Oncology
5 Year Journal's Impact IF Trend · Prediction · Ranking · Key Factor Analysis

Homepage · Submit Manuscript · Wikipedia

Weighted Average of SCImango Dataset

Cites / Doc. (5 years)

2021-2022

12.42

15.4%

Cites / Doc. (5 years)

One-click to visualize your research performance

Researchain.net

One-click to visualize your research performance

Researchain.net

One-click to visualize your research performance

Researchain.net

One-click to visualize your research performance

Researchain.net

Popular Journals

Highly Cited Articles

Journal of Clinical Oncology

High Impact Research Articles

Publication Title	Author Listing
Publication Title	Author Listing
Phase I/II study of ramucirumab plus nivolumab in patients in second-line treatment for advanced gastric adenocarcinoma (NivoRam study).	Hiroki Hara · Hirokazu Shoji · Daisuke Takahari · Taito Esaki · Nozomu Machida · Kengo Nagashima · Kazunori Aoki · Kazufumi Honda · Takahiro Miyamoto · Narikazu Boku · Ken Kato
The relationship between tumor budding, tumor microenvironment, and survival in patients with primary operable colorectal cancer.	Hester C. van Wyk · Antonia K. Roseweir · Ditte Anderson · Elizabeth J. Sutton · Paul G. Horgan · Donald C. McMillan · Joanne Edwards
Ph1/2 study of Rova-T in combination with nivolumab (Nivo) ± ipilimumab (Ipi) for patients (pts) with 2L+ extensive-stage (ED) SCLC.	Jyoti Malhotra · Petros Nikolinakos · Ticiana Leal · Jonathan M. Lehman · Daniel Morgensztern · Jyoti D. Patel · John Wrangle · Giuseppe Curigliano · Eric Dansin · Laurent Greillier · Melissa L. Johnson · Neal Ready · Gilles Robinet · Satwant Lally · Shekman Wong · Emin Avsar · Ricardo Valenzuela · Charity D. Scripture · Giovanni Selvaggi · Benjamin Besse
Randomized study evaluating trifluridine/tipiracil (TAS-102) versus + trifluridine/tipiracil + bevacizumab as last-line therapy in patients with chemorefractory unresectable metastatic colorectal cancer (mCRC).	Per Pfeiffer · Mette Karen Yilmaz · Søren Møller · Line Maltha · Merete Krogh · Daniela Zitnjak · Caroline Lemb Szameitat · Finn Hejlesen · Karina Gravgaard Thomsen · Camilla Qvortrup
Phase 3 randomized study of daratumumab (DARA) + bortezomib/thalidomide/dexamethasone (D-VTd) vs VTd in transplant-eligible (TE) newly diagnosed multiple myeloma (NDMM): CASSIOPEIA Part 1 results.	Philippe Moreau · Michel Attal · Cyrille Hulin · Marie-Christine Béné · Annemiek Broijl · Denis Caillot · Michel Delforge · Thomas Dejoie · Thierry Facon · Jérôme Lambert · Xavier Leleu · Margaret Macro · Aurore Perrot · Sonja Zweegman · Tahamtan Ahmadi · Christopher Chiu · Lixia Pei · Jessica Vermeulen · Hervé Avet-Loiseau · Pieter Sonneveld · Hovon
Plasmacytoid variant urothelial carcinoma: Clinicopathologic outcomes and experience with neoadjuvant chemotherapy.	Kyle Ericson · Lewis Thomas · Byron H. Lee
Maintenance olaparib after platinum-based chemotherapy in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Efficacy by surgical and tumor status in the Phase III SOLO1 trial.	C. Mathews · Kathleen N. Moore · Nicoletta Colombo · Giovanni Scambia · Byoung-Gie Kim · Ana Oaknin · Michael Friedlander · Alla Sergeevna Lisyanskaya · Anne Floquet · Alexandra Leary · Gabe S. Sonke · Charlie Gourley · Susana Banerjee · Amit M. Oza · Antonio González-Martín · Carol Aghajanian · William H. Bradley · Elizabeth S. Lowe · Ralph Bloomfield · Paul DiSilvestro
A dose escalation pharmacokinetic (PK) and pharmacodynamic (PD) study of mTORC1/2 inhibitor XP-105 (BI 860585) as monotherapy and in combination with exemestane or paclitaxel in patients (pts) with advanced solid tumors.	Filippo de Braud · Wentao Jason Wu
Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in patients with testis cancer in the salvage setting.	Peter Albers · Alessandro Nini · Andreas Hiester · C. Winter · Achim Lusch · Anja Lorch
Efficacy of abiraterone and enzalutamide in patients who had disease progression within twelve months of completing docetaxel for metastatic castration sensitive prostate cancer.	Gang Chen · David J. VanderWeele · Fatima Karzai · Marijo Bilusic · Munjid Al Harthy · Philip M. Arlen · Inger L. Rosner · Guinevere Chun · Helen Owens · Anna Couvillon · Amy Hankin · Monique Williams · Lisa M. Cordes · William D. Figg · James L. Gulley · William L. Dahut · Ravi A. Madan
Combined effect of radiotherapy and anthracyclines on risk of breast cancer among female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS).	Lene H. S. Veiga · Rochelle E. Curtis · Lindsay M. Morton · Diana Withrow · Rebecca Maureen Howell · Susan A. Smith · Rita E. Weathers · Kevin C. Oeffinger · Chaya S. Moskowitz · Tara O. Henderson · Michael A. Arnold · Todd M. Gibson · Wendy M. Leisenring · Joseph Philip Neglia · Lucie M. Turcotte · John Whitton · Leslie L. Robison · Peter D. Inskip · Gregory T. Armstrong · Amy Berrington de Gonzalez
External validation of the COMPASS-Cancer Associated Thrombosis Study: A predictive score to identify patients with solid tumors on treatment who are at risk for venous thromboembolism.	Lalitha N Anand · Alex C. Spyropoulos · Joanna B Eldredge · Soheila Nourabadi · Meng Zhang · Michael Qiu · D. M. Rosenberg
Safety and efficacy of nimotuzumab and concurrent intensity-modulated radiation therapy and chemotherapy for locally advanced cervical squamous cell cancer.	Ang Qu · Junjie Wang · Ping Jiang · Panfeng Wang · Muyi Zhang · Xu Li · Haitao Sun
Racial disparities in radium-223 treatment in a large real-world population.	Hanson Zhao · Lauren E. Howard · Amanda De Hoedt · Martha Kennedy Terris · Christopher L. Amling · Christopher J. Kane · Matthew R. Cooperberg · William J. Aronson · Thomas J. Polascik · Stephen J. Freedland
From presentation to paper: Gender disparities in oncological research.	Willemieke P.M. Dijksterhuis · Charlotte I. Stroes · Wan Ling Tan · Suthinee Ithimakin · Antonio Calles · Jorge Barriuso · Sjoukje F. Oosting · Daniela Kolarevic · Andrew J.S. Furness · Ivana Bozovic · Carlos Gomez-Roca · Hanneke W. M. van Laarhoven
A novel anti-CD19 chimeric T cell therapy platform ET019002 was safe and effective in inducing CR in blast crisis of CML: A case study.	Pengcheng He · Hong Liu · Haibo Liu · Qijing Li · Mina Luo · Hui Feng · Kai Ye · Bijan Nejadnik · Bingyin Shi · Cheng Liu
Combined radiotherapy and transarterial chemoembolization as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion.	Sang Min Yoon · Ji Hyeon Joo · Jinhong Jung · Yeon Joo Kim · Jin-hong Park · Jong Hoon Kim
Effect of smoking on the efficacy of immune checkpoint inhibitors in advanced cancers: A systematic review and meta-analysis.	Chia Ching Lee · Ivan Weng Keong Tham · Yu Yang Soon · J. Tey
HIF1A genetic variability and late adverse events of radiotherapy in breast cancer.	T. Marinko · Katja Goričar · Vita Dolzan
A germline microRNA-based biomarker signature of immune-associated toxicity to anti-PD1/PDL1 therapy.	Joanne B. Weidhaas · Aaron Scheffler · David W. Salzman · Anusha Kalbasi · Kirk Wilenius · Emily Rietdorf · Mara Heilig · Mattias Pitka · Caroline Desler · Dan Ruan · Antoni Ribas · Alexandra Drakaki · Mark C. Scholz · Donatello Telesca
Lack of clinician knowledge of human papillomavirus (HPV) vaccination to prevent HPV-related cancers in men: An interview study.	Stefan Varga · Suepattra G. May · Edith Morais · A. Shrestha · Caroline Huber · Anupama Tantri · Meaghan Roach · Matthew Phillips · Anupam B. Jena
The impact of muscle mass loss after esophagectomy for esophageal cancer on prognosis.	Yota Shimoda · Takashi Ogata · Shinsuke Nagasawa · Yuta Kumazu · Tsutomu Hayashi · Takanobu Yamada · Takashi Oshima
Health care utilization associated with adverse events (AEs) among metastatic non-small cell lung cancer (mNSCLC) patients treated with immunotherapy or chemotherapy.	Nicole M. Engel-Nitz · Kellie Ryan · Michael P Johnson · Scott Bunner
Using PIK3CB and connexin-43 inhibition to sensitize pediatric glioblastoma cells to temozolomide.	Farah Shah · Zhi Sheng
Barriers to minority recruitment in a multicenter clinical trial (PRO-TECT [AFT-39]): Research staff insights.	Marjory Charlot · Sydney Henson · Patty Spears · Deborah Schrag · Angela M. Stover · Ethan Basch
Neoadjuvant chemotherapy versus upfront resection in ampullary adenocarcinoma stratified by stage: A retrospective analysis using the National Cancer Database.	Shravan Leonard-Murali · Rupen A. Shah · Tommy Ivanics · Xiaoxia Han · Christopher P. Steffes · David S. Kwon
Outcomes of tbo-filgrastim, filgrastim-sndz or filgrastim for mobilization in patients undergoing an autologous hematopoietic stem cell transplant: A single center experience.	Klodiana Neme · David Henkin · Nancy Mikulandric · Meredith Grycki · Angela Michael · Cassandra Smith · Josephine Emole
Express study: A trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors.	Olivia Le Saux · Antoine Italiano · Fabrice Andre · Thomas Filleron · Dominique Spaeth · Pierre-Etienne Heudel · Laurence Albiges · Thomas Bachelot · Anthony Gonçalves · Jean-Yves Pierga · Fabrice Barlesi · Valérie Boige · Celeste Lebbe · Laurent Mortier · Jean-Sébastien Frenel · Olivier Tredan · Marta Jimenez · François Legrand · Charles Ferté
Unique racial patterns in rare T-cell lymphomas: A National Cancer Registry analysis from 2001 to 2015.	Nishi N Shah · Diego Andres Adrianzen Herrera · Urvi A. Shah · Bhaskar Kolla · Gurbakhash Kaur · Roberto Alejandro Sica · Aditi Shastri · Ioannis Mantzaris · Amit Verma · Murali Janakiram
A prospective study of robotic rectal surgery for carcinoma rectum assessing the functional and oncological outcomes: Hype or hope?	S. P. Somashekhar · C RohitKumar · Ashwin K Rajgopal · Shabber Zaveri · Amit Rauthan · Ramya Yethadka
Prognostic value of circulating cytokines in colorectal cancer: A prospective study in sixty colorectal cancer patients in Tunisia.	J Ayari · Rania Guesmi · M Balti · Mouna Ben Azaiz · A Zribi · S Fendri · Sonia Ben Nasr · Ezzedine Ghazouani · Faida Agili · Sharif Ahmed Kullab · A Haddaoui
Building international partnerships to improve global oncological care: Perspective from Rutgers-CINJ Global Oncology Fellowship Program.	Ashwin Chandar · Sukhdeep Kaur · Deborah Toppmeyer · Tlotlo Bathethi Ralefala · Roger Strair · Claire S. Philipp · Richard Marlink · Reena Antony · Marilyn DiGiacobbe · Refeletswe Lebelonyane · Tendani Gaolathe · Tina M. Mayer
Retrospective analysis of patients with sentinel lymph node (SLN) positive melanoma (MEL) who received adjuvant nivolumab (NIVO) without completion lymph node dissection (CLND).	Zeynep Eroglu · Nalan Akgül Babacan · Kenneth F. Grossmann · Joseph Markowitz · Andrew S. Brohl · Jennifer Cisneros · Wayne Cruse · Michael A. Harrington · Ricardo J. Gonzalez · Amod A. Sarnaik · Jonathan S. Zager · Vernon K. Sondak · Nikhil I. Khushalani
Temporal trends and disease characteristics associated with total neoadjuvant therapy (TNT) usage.	Laila Babar · Veli Bakalov · Stephen Abel · Gene Grant Finley · Moses S. Raj · Dulabh K. Monga · Alexander V. Kirichenko · Rodney E. Wegner
Training and validation study for sequential monitoring of CAMLs in circulation to predict ongoing progression in lung cancer patients undergoing definitive radiotherapy.	Daniel E. Adams · Jianzhong He · Yawei Qiao · Ting Xu · Hui Gao · James M. Reuben · Ritsuko Komaki · Zhongxing X. Liao · Ignacio I. Wistuba · Ashvathi Raghavakaimal · Cha-Mei Tang · Alexander Augustyn · Steven Hsesheng Lin
Re-examining an old trend: The association of human papillomavirus and bladder cancer.	Lael Reinstatler · Kevin Shee · Kristian D. Stensland · Lawrence M. Dagrosa · John D. Seigne · Einar F. Sverrisson
Patient related outcomes in cancer patients in Croatia.	Dragan Trivanovic · Irena Hrstic · Anuska Budisavljevic · Boris Kopic · Bruno Nincevic
Patient-reported distress and symptoms predict post-esophagectomy outcomes.	Jonathan C. Salo · Patrick Leland Meadors · Sally J. Trufan · Nicole Gower · Michael Watson · Lauren A. Jeck · Joshua S. Hill · Declan Walsh
Antiviral therapy to reduce hepatocellular carcinoma recurrence in patients with low HBV-DNA levels: A randomized controlled trial.	Gang Huang · Peng-peng Li · Wan Yee Lau · Ze-ya Pan · Ling-Hao Zhao · Zhen-Guang Wang · Meng-chao Wang · Weiping Zhou
The impact of histology (adenocarcinoma vs. SCC) on outcomes in nonmetastatic pancreatic cancer.	Joshua D. Gruhl · Samual Francis · Randa Tao · Benjamin Solomon · Christopher Duane Nevala-Plagemann · Ignacio Garrido-Laguna · Shane Lloyd
Assessment of the diagnostic value of microsatellite instability in the urine of bladder cancer patients.	Hussein Mustafa Khaled · Abdel-Rahman N. Zekri · Mai B Mohamed · Fatma M. Diab · Mona S. Abdellateif · Somaya Cancer El Deeb · Abeer M. Badr · Sanaa O. Abdallah · Abeer A. Bahnassy
Do oral antineoplastic treatment data differ between Concerto Health AI Definitive Oncology EMR and Symphony Claims Data	Laura Chu · Nayan Chaudhary · Li Chen · William Bruce Wong
Relationship of emergency department use pre- and post-cancer diagnosis in safety-net adults.	Arthur S. Hong · Navid Sadeghi · John V. Cox · Simon J. Craddock Lee · Ethan A. Halm
Patient and disease characteristics of colorectal cancer in a cohort of young patients.	Wissam Hanayneh · Thomas J. George · Thomas Read · Sanda A. Tan · Atif Iqbal · Carmen J. Allegra · Hiral D. Parekh
Development of a radiomics nomogram based on the CE-CT features to predict the survival of upfront resectable patients with pancreatic head cancer and suspected venous invasion.	Yi-Nan Shen · Tian-Yu Tang · Xueli Bai · Tingbo Liang
A general approach to optimizing tumor treating fields therapy.	Zeev Bomzon · Noa Urman · H. S. Hershkovich · Eilon D. Kirson · Ariel Naveh · Reuven Shamir · Eduard Federov · Cornelia Wenger · Uri Weinberg
Incidence of pulmonary metastasis among patients with colorectal adenocarcinoma: Correlation between sidedness and RAS mutations.	Lara Azevedo Diniz · Diogo De Brito Sales · Larissa Machado · Amanda Karani · Milton Jose Barros · Rodrigo Gomes Taboada · Natasha Carvalho Pandolfi · Poliana de Andrade · Helano C. Freitas
Analysis of circulating tumor DNA to monitor metastatic breast cancer patients treated with first-line chemotherapy (CAMELLIA study).	Zongbi Yi · Fei Ma · Guohua Rong · Jin Li · Lianpeng Chang · Yanfang Guan · Binliang Liu · Xiuwen Guan · Lixi Li · Chunxiao Li · Jingtong Zhai · Haili Qian · Binghe Xu
Racial comparisons in receipt of timely guideline-based colon cancer treatment in an equal-access health system.	Yvonne L. Eaglehouse · Matthew W. Georg · Craig D. Shriver · Kangmin Zhu
Phase I study of CC-90010 in patients with advanced solid tumors and relapsed/refractory non-Hodgkin lymphoma (R/R NHL).	Victor Moreno · Irene Brana · Juan Manuel Manuel Sepulveda Sanchez · Maria Vieito Villar · Tatiana Hernandez-Guerrero · Bernard Doger · Omar Saavedra · Olga Ferrero · Rafael Sarmiento · Marina Arias · Juan De Alvaro · Jorge DiMartino · Marlene Zuraek · Tania Sánchez Pérez · Ellen H. Filvaroff · Ida Aronchik · Manisha Lamba · Bishoy Hanna · Zariana Nikolova

Highly Cited Keywords

Journal of Clinical Oncology

High Impact Research Keywords

Journal Research Scope

Journal of Clinical Oncology

Research Scope

cancer patients cell metastatic advanced phase trial carcinoma breast therapy lung analysis treatment clinical prostate outcomes tumor treated chemotherapy II survival care randomized colorectal response non-small tumors pts inhibitors renal efficacy immune versus combination Phase checkpoint stage pancreatic oncology solid DNA NSCLC neoadjuvant Cancer radiotherapy results expression receptor adenocarcinoma Results experience inhibitor squamous cohort first-line head III cancers multicenter Association safety gastric patient high-risk risk melanoma Clinical circulating urothelial neck disease progression population retrospective impact adjuvant leukemia ovarian lymphoma factors prognostic prognosis review nivolumab cells associated hepatocellular androgen role trials PD-L1 burden repair bladder patterns diagnosis data women status elderly

Research Scope

Journal of Clinical Oncology

Research Scope

cancer patients cell metastatic advanced phase trial carcinoma breast therapy lung analysis treatment clinical prostate outcomes tumor treated chemotherapy II

Journal's Impact IF Ranking

Journal of Clinical Oncology

Journal's Impact IF Ranking

Subcategory	Quartile	Rank	Percentile
Cancer Research	Q1	4/207	Cancer Research 98%
Oncology	Q1	7/340	Oncology 98%

Key Factor Analysis

Journal's Impact IF Ranking

Related Journals

Journal of Clinical Oncology

Similar Journals

Angiogenesis Cancer Research Liver Cancer Journal of the National Comprehensive Cancer Network : JNCCN Cancer Treatment Reviews Cancer immunology research Leukemia Blood Cancer Journal Oncogene Biochimica et Biophysica Acta - Reviews on Cancer Cancer Letters European Journal of Cancer Gastric Cancer Therapeutic Advances in Medical Oncology Molecular Oncology Cancer and Metastasis Reviews Cell Death and Disease Oncogenesis Nature Reviews Clinical Oncology Nature Reviews Cancer OncoImmunology International Journal of Radiation Oncology Biology Physics Critical Reviews in Oncology/Hematology Blood Reviews British Journal of Cancer Cancer Neoplasia Molecular Cancer Therapeutics Cancer Immunology, Immunotherapy Cancer Biology and Medicine Cellular Oncology Advances in Cancer Research PLoS Genetics International Journal of Cancer Translational Lung Cancer Research Oncologist Breast Cancer Research Cancer Science Oncology Research Radiotherapy and Oncology Frontiers in Oncology Endocrine-Related Cancer Lung Cancer Cancer Nanotechnology Molecular Cancer Research Gynecologic Oncology Carcinogenesis Apoptosis : an international journal on programmed cell death Cancer Gene Therapy Cancer Epidemiology Biomarkers and Prevention Prostate Cancer and Prostatic Diseases Epigenetics Cytotherapy Seminars in Oncology Molecular Therapy - Oncolytics Epigenomics Journal of immunotherapy (Hagerstown, Md. : 1997) Seminars in Radiation Oncology Annals of Surgical Oncology Targeted Oncology The Lancet Oncology Oral Oncology European Journal of Surgical Oncology Current Treatment Options in Oncology International Journal of Oncology Breast Cancer Research and Treatment Current Oncology Reports Molecular Carcinogenesis Cancer Cytopathology Cancer Research and Treatment Breast Current Opinion in HIV and AIDS Acta Oncologica Pigment Cell and Melanoma Research Cancer Biology and Therapy Open Forum Infectious Diseases Journal of Cancer Research and Clinical Oncology International Journal of Hyperthermia Expert Review of Anticancer Therapy Journal of Cancer Translational Oncology Journal of Oncology Practice Clinical Lung Cancer United European Gastroenterology Journal Investigational New Drugs Cancer Medicine Cancer Prevention Research Human Cell Genes Chromosomes and Cancer Cancer Biomarkers Oncology Reports American Journal of Translational Research OncoTargets and Therapy Current Opinion in Oncology Nitric Oxide - Biology and Chemistry Journal of Gynecologic Oncology Journal of Cancer Survivorship Journal of Mammary Gland Biology and Neoplasia Cancer Genomics and Proteomics Prostate More Related Journals

Journal of Clinical Oncology

The 2021-2022 5 Year Cites / Doc. of Journal of Clinical Oncology is 12.42, which is just updated in 2022.

Journal of Clinical Oncology Journal's Impact IF

Journal of Clinical Oncology

Journal Key Metrics

Journal Title	Journal of Clinical Oncology
ISSN	0732-183X
ISSN (Online)	1527-7755
Publisher	American Society of Clinical Oncology
Publication Frequency	Three times a month
Coverage	1983 - Present
Open Access	NO
Language	English
Publication Fee	https://academic-accelerator.com//Publication-Fee/Journal-of-Clinical-Oncology
Homepage	https://ascopubs.org/journal/jco
Submit Manuscript	https://www.editorialmanager.com/jco-ascopubs/default.aspx
Wikipedia	http://en.wikipedia.org/wiki/Journal_of_Clinical_Oncology

Journal of Clinical Oncology

Journal's Impact IF 2022-2023 Prediction

Journal of Clinical Oncology Journal's Impact IF Prediction System is now online. You can start share your valuable insights with the community.

Journal's Impact IF Predition System

Predict Check All Preditions

Journal of Clinical Oncology

Journal Profile

About

The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer. The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the American Society of Clinical Oncology. It covers research on all aspects of clinical oncology. All articles older than one year are freely available online. The journal was established in 1983 and the editor-in-chief is Stephen A. Cannistra (Harvard Medical School).

ISSN

0732-183X

Key Factor Analysis

ISSN

The ISSN of Journal of Clinical Oncology is 0732-183X . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
Journal of Clinical Oncology Key Factor Analysis

ISSN (Online)

1527-7755

Key Factor Analysis

ISSN (Online)

The ISSN (Online) of Journal of Clinical Oncology is 1527-7755 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
Journal of Clinical Oncology Key Factor Analysis

Publisher

American Society of Clinical Oncology

Key Factor Analysis

Publisher

Journal of Clinical Oncology is published by American Society of Clinical Oncology .
Journal of Clinical Oncology Key Factor Analysis

Publication Frequency

Three times a month

Key Factor Analysis

Publication Frequency

Journal of Clinical Oncology publishes reports Three times a month .
Journal of Clinical Oncology Key Factor Analysis

Coverage

1983 - Present

Key Factor Analysis

Coverage

The Publication History of Journal of Clinical Oncology covers 1983 - Present .
Journal of Clinical Oncology Key Factor Analysis

Open Access

Key Factor Analysis

Open Access

Journal of Clinical Oncology Key Factor Analysis

Publication Fee

Review

Key Factor Analysis

Publication Fee

Journal of Clinical Oncology Key Factor Analysis

Language

English

Key Factor Analysis

Language

The language of Journal of Clinical Oncology is English .
Journal of Clinical Oncology Key Factor Analysis

Country/Region

United States

Key Factor Analysis

Country/Region

The publisher of Journal of Clinical Oncology is American Society of Clinical Oncology , which locates in United States .
Journal of Clinical Oncology Key Factor Analysis

International Collaboration Trend

Journal of Clinical Oncology

Cited Documents Trend

Journal of Clinical Oncology

Total Publications

118341

Total Citations

4065362

Annual Publication Volume

Journal of Clinical Oncology

Annual Citation Record

Journal of Clinical Oncology

Publications Cites Dataset

Journal of Clinical Oncology

Year	Publications	Citations
Year	Publications	Citations
1980	0	5
1981	0	4
1982	0	7
1983	116	72
1984	216	599
1985	251	1581
1986	284	2835
1987	317	4635
1988	268	5536
1989	284	8465
1990	299	10421
1991	322	13935
1992	303	14914
1993	371	18107
1994	413	19607
1995	434	21980
1996	444	26612
1997	480	29430
1998	603	35017
1999	579	43933
2000	603	52303
2001	651	61299
2002	769	71165
2003	846	86564
2004	4369	91190
2005	4974	114722
2006	4867	146800
2007	5120	156277
2008	5328	175064
2009	5204	192710
2010	5851	214842
2011	6714	234577
2012	7189	261801
2013	6824	270068
2014	7348	259897
2015	7247	265715
2016	7698	244827
2017	7710	240156
2018	7923	198958
2019	7316	205812
2020	7728	244977
2021	76	17943

Key Factor Analysis

Publications Cites Dataset

· The total publications of Journal of Clinical Oncology is 118341.
Journal of Clinical Oncology Key Factor Analysis

· The total citations of Journal of Clinical Oncology is 4065362.
Journal of Clinical Oncology Key Factor Analysis

Journal of Clinical Oncology 5 Year Journal's Impact IF Trend · Prediction · Ranking · Key Factor Analysis

Cites / Doc. (5 years)

2021-2022

Cites / Doc. (5 years)

One-click to visualize your research performance

One-click to visualize your research performance

One-click to visualize your research performance

One-click to visualize your research performance

Popular Journals

Highly Cited Articles

Journal of Clinical Oncology

High Impact Research Articles

Highly Cited Keywords

Journal of Clinical Oncology

High Impact Research Keywords

Journal Research Scope

Journal of Clinical Oncology

Research Scope

Research Scope

Journal of Clinical Oncology

Research Scope

Journal's Impact IF Ranking

Journal of Clinical Oncology

Journal's Impact IF Ranking

Cancer Research 98%

Oncology 98%

Related Journals

Journal of Clinical Oncology

Similar Journals

Journal of Clinical Oncology

Journal of Clinical Oncology

Journal Key Metrics

Journal of Clinical Oncology

Journal's Impact IF 2022-2023 Prediction

About

The ISSN of Journal of Clinical Oncology is 0732-183X . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic. Journal of Clinical Oncology Key Factor Analysis

The ISSN (Online) of Journal of Clinical Oncology is 1527-7755 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic. Journal of Clinical Oncology Key Factor Analysis

Journal of Clinical Oncology is published by American Society of Clinical Oncology . Journal of Clinical Oncology Key Factor Analysis

Journal of Clinical Oncology publishes reports Three times a month . Journal of Clinical Oncology Key Factor Analysis

The Publication History of Journal of Clinical Oncology covers 1983 - Present . Journal of Clinical Oncology Key Factor Analysis

Journal of Clinical Oncology Key Factor Analysis

Journal of Clinical Oncology Key Factor Analysis

The language of Journal of Clinical Oncology is English . Journal of Clinical Oncology Key Factor Analysis

The publisher of Journal of Clinical Oncology is American Society of Clinical Oncology , which locates in United States . Journal of Clinical Oncology Key Factor Analysis

International Collaboration Trend

Journal of Clinical Oncology

Cited Documents Trend

Journal of Clinical Oncology

Annual Publication Volume

Journal of Clinical Oncology

Annual Citation Record

Journal of Clinical Oncology

Publications Cites Dataset

Journal of Clinical Oncology

· The total publications of Journal of Clinical Oncology is 118341. Journal of Clinical Oncology Key Factor Analysis · The total citations of Journal of Clinical Oncology is 4065362. Journal of Clinical Oncology Key Factor Analysis

Journal of Clinical Oncology
5 Year Journal's Impact IF Trend · Prediction · Ranking · Key Factor Analysis

The ISSN of Journal of Clinical Oncology is 0732-183X . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
Journal of Clinical Oncology Key Factor Analysis

The ISSN (Online) of Journal of Clinical Oncology is 1527-7755 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
Journal of Clinical Oncology Key Factor Analysis

Journal of Clinical Oncology is published by American Society of Clinical Oncology .
Journal of Clinical Oncology Key Factor Analysis

Journal of Clinical Oncology publishes reports Three times a month .
Journal of Clinical Oncology Key Factor Analysis

The Publication History of Journal of Clinical Oncology covers 1983 - Present .
Journal of Clinical Oncology Key Factor Analysis

The language of Journal of Clinical Oncology is English .
Journal of Clinical Oncology Key Factor Analysis

The publisher of Journal of Clinical Oncology is American Society of Clinical Oncology , which locates in United States .
Journal of Clinical Oncology Key Factor Analysis

· The total publications of Journal of Clinical Oncology is 118341.
Journal of Clinical Oncology Key Factor Analysis

· The total citations of Journal of Clinical Oncology is 4065362.
Journal of Clinical Oncology Key Factor Analysis